PHILADELPHIA, Jan. 15, 2016 (GLOBE NEWSWIRE) -- Chemtura Corporation (NYSE:CHMT) (EURONEXT:CHMT) announced it will release its Fourth Quarter and Full Year 2015 earnings and file its Annual Report on Form 10-K on Monday, February 22, 2016, after the market closes.
The Company will host a teleconference to review these results on Tuesday, February 23, 2016 at 9:00 a.m. (EDT). A copy of the earnings press release and webcast information will be available on the Investor Relations section of Company’s web site at http://investor.chemtura.com.
Interested parties are asked to dial in approximately 10 minutes prior to the start time.
The dial-in numbers are:
Domestic Toll-Free: (877) 633-3602
International: (404) 665-9523
The conference ID code is: 29087377
A replay of the call will be available for thirty days, starting at 10:00 AM (EDT) Tuesday, February 23, 2016. To access the replay, call (855) 859-2056, or
(404) 537-3406, and enter access code 29087377
WEBCAST LINK:
Webcast access will be available on the morning of the call.
http://edge.media-server.com/m/p/q2kqm67b
Chemtura Corporation, with 2014 sales of $2.2 billion, is a global manufacturer and marketer of specialty chemicals. Additional information concerning Chemtura is available at www.chemtura.com.
Matthew Sokol Director, Investor Relations and Corporate Development Tel: (203) 573-2153


Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



